All posts by: Michael Zand

The Newest, Undiscovered CAR-T Play with a Rock-Star Partner Portfolio & Significant Near-Term Upside Potential – Baystreet.ca

The Newest, Undiscovered CAR-T Play with a Rock-Star Partner Portfolio & Significant Near-Term Upside PotentialBaystreet.caNewly NASDAQ-listed cell therapy manufacturer Orgenesis (ORGS) growing revenue in mega-blockbuster cell therapy industry. Com… Continue reading

Breakthrough microscope revolutionizes live cell imaging of stem cells – News-Medical.net

News-Medical.netBreakthrough microscope revolutionizes live cell imaging of stem cellsNews-Medical.netTherefore, with relatively robust cell types such as cancer cell lines, a tradeoff must be found between short live cell imaging with high-frequency a… Continue reading

Global CRISPR Technology Market to Reach $10.55 Billion by 2027, Reports BIS Research – PR Newswire (press release)

Global CRISPR Technology Market to Reach $10.55 Billion by 2027, Reports BIS ResearchPR Newswire (press release)According to Pushplata Patel an analyst at BIS Research "North America is the leading contributor to the global CRISPR technology marke… Continue reading

BioCardia Presents at Alliance for Regenerative Medicine’s (ARM’s) Annual Cell & Gene Therapy Investor Day – PR Newswire (press release)

BioCardia Presents at Alliance for Regenerative Medicine’s (ARM’s) Annual Cell & Gene Therapy Investor Day PR Newswire (press release) SAN CARLOS, Calif., April 18, 2018 /PRNewswire/ — BioCardia®, Inc., [OTC: BCDA] a leader in cardiovascular regenerative medicine, today announced that it was among the companies providing presentations at the Alliance for Regenerative Medicine’s (ARM … and more »